Comparision of cyclosporine and prednisolone in treatment of lichen planus.
Phase 4
- Conditions
- Health Condition 1: L433- Subacute (active) lichen planus
- Registration Number
- CTRI/2024/05/068053
- Lead Sponsor
- Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER Pondicherry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients with symptomatic active oral or mucocutaneous lichenplanus with BSA greater than 5 % who needs systenic therapy
Symptomatic lesions of reticular, atrophic and
erosive OLP, based on the clinical and
histopathological criteria of the WHO (1978) and
modified by van der Meij and van der Waal.
Patients of oral LP with treatment failure after 4
weeks of topical therapy.
Exclusion Criteria
Patients with treatment naive mild lichen
planus
Patient with renal impairment
Pregnancy,lactation and with serious medical
illness
Contraindications for Prednisolone/cyclosporine
8 weeks
Defnitive drug induced lichenoid eruption
Nail and hair,lichen planus, lichen planus
pigmentosus
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method